Cancer News
Most Popular Cancer Story
The roller coaster ride of melanoma drug development
This week, the New York Times is tracing the Phase I testing of a novel melanoma drug being developed by Plexxikon and Roche. The paper says to chronicle the three years of PLX4032 testing "is to... Read more...
Latest Headlines
- March 1, 2010
- February 22, 2010
- January 19, 2010
- November 30, 2009
- November 3, 2009
- October 26, 2009
- October 6, 2009
- September 15, 2009
- August 31, 2009
- August 25, 2009
- August 3, 2009
- June 23, 2009
- June 2, 2009
- April 14, 2009
- March 24, 2009
- February 24, 2009
- January 6, 2009
- December 16, 2008
- November 25, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
